LSD1 inhibition in pHGG: The key to unleashing immunotherapy?

Theodore P. Nicolaides*, Rintaro Hashizume

*Corresponding author for this work

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)1237-1238
Number of pages2
JournalNeuro-oncology
Volume22
Issue number9
DOIs
StatePublished - Sep 1 2020

ASJC Scopus subject areas

  • Oncology
  • Clinical Neurology
  • Cancer Research

Cite this